Abstract
Telomerase, a ribonucleic acid-protein complex, adds hexameric repeats of 5'-TTAGGG-3' to the ends of mammalian chromosomal DNA (telomeres) to compensate for the progressive loss that occurs with successive rounds of DNA replication. Although somatic cells do not express telomerase, germ cells and immortalized cells, including neoplastic cells, express this activity. To determine whether the phenotypic differentiation of immortalized cells is linked to the regulation of telomerase activity, terminal differentiation was induced in leukemic cell lines by diverse agents. A pronounced downregulation of telomerase activity was produced as a consequence of the differentiated status. The differentiation-inducing agents did not directly inhibit telomerase activity, suggesting that the inhibition of telomerase activity is in response to induction of differentiation. The loss of telomerase activity was not due to the production of an inhibitor, since extracts from differentiated cells did not cause inhibition of telomerase activity. By using additional cell lineages including epithelial and embryonal stem cells, down-regulation of telomerase activity was found to be a general response to the induction of differentiation. These findings provide the first direct link between telomerase activity and terminal differentiation and may provide a model to study regulation of telomerase activity.
MeSH Terms
Animals
Base Sequence
Butyrates/pharmacology
Butyric Acid
Calcitriol/pharmacology
Cell Differentiation/drug effects,physiology
Cell Line
Cell Nucleus/enzymology
Colonic Neoplasms
Cytoplasm/enzymology
Dimethyl Sulfoxide/pharmacology
Growth Inhibitors/pharmacology
HL-60 Cells
Humans
Interleukin-6
Kidney
Leukemia Inhibitory Factor
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Lymphokines/pharmacology
Mice
Repetitive Sequences, Nucleic Acid
Stem Cells
Telomerase/metabolism
Teratocarcinoma
Tetradecanoylphorbol Acetate/pharmacology
Tretinoin/pharmacology
Tumor Cells, Cultured
Chemicals
Butyrates
Growth Inhibitors
Interleukin-6
LIF protein, human
Leukemia Inhibitory Factor
Lif protein, mouse
Lymphokines
Butyric Acid
Tretinoin
Telomerase
Calcitriol
Tetradecanoylphorbol Acetate
Dimethyl Sulfoxide
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Sharma H W
Division of Oncology, Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110, USA.
Sokoloski J A
Perez J R
Maltese J Y
Sartorelli A C
Stein C A
Nichols G
Khaled Z
Telang N T
Narayanan R
References (14)
14 references, click to expand
-
Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP.
Cell. 1980 Sep;21(2):347-55
PMID: 6250719
-
Myeloid and megakaryocytic properties of K-562 cell lines.
Cancer Res. 1983 Oct;43(10):4569-74
PMID: 6349795
-
Mechanism of transcriptional activation by Sp1: evidence for coactivators.
Cell. 1990 Jun 29;61(7):1187-97
PMID: 2194667
-
Telomere loss: mitotic clock or genetic time bomb?
Mutat Res. 1991 Mar-Nov;256(2-6):271-82
PMID: 1722017
-
Evidence for differential functions of the p50 and p65 subunits of NF-kappa B with a cell adhesion model.
Mol Cell Biol. 1993 Jun;13(6):3802-10
PMID: 8497281
-
Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes.
Blood. 1993 Jul 15;82(2):625-32
PMID: 8101106
-
Is telomerase a universal cancer target?
J Natl Cancer Inst. 1995 Jun 21;87(12):859-61
PMID: 7666470
-
Telomerase activity in germline and embryonic cells of Xenopus.
EMBO J. 1994 Jul 1;13(13):3211-7
PMID: 8039513
-
Telomere dynamics in an immortal human cell line.
EMBO J. 1994 Oct 17;13(20):4953-62
PMID: 7957062
-
Specific association of human telomerase activity with immortal cells and cancer.
Science. 1994 Dec 23;266(5193):2011-5
PMID: 7605428
-
Telomeres, cancer, and immortality.
N Engl J Med. 1995 Apr 6;332(14):955-6
PMID: 7877656
-
Telomerase activity in normal leukocytes and in hematologic malignancies.
Blood. 1995 May 1;85(9):2315-20
PMID: 7727765
-
Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
Cancer Res. 1995 Jul 1;55(13):2734-6
PMID: 7796395
-
Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression.
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9901-5
PMID: 8234333